Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Reversible TET Inhibitor As a Hematopoietic Stem Cell Booster: A Novel Strategy to Improve Stem Cell Function

Blood (2019) 134 (Supplement_1): 2472.

https://doi.org/10.1182/blood-2019-129056

Published: 2019

Journal Articles

Targeting NAD + Modulating Enzymes to Improve HSC Function in Aging and Bone Marrow Failure

Phillip J Maciejewski, Yihong Guan, Metis Hasipek, PhD, Anand D. Tiwari, PhD, Dale Grabowski, BS, James G Phillips, PhD, Yogenthiran Saunthararajah, MD, Jaroslaw P. Maciejewski, Babal K. Jha

Blood (2018) 132 (Supplement 1): 3840.

https://doi.org/10.1182/blood-2018-99-119300

Published: 2018

Journal Articles

Therapeutic Targeting of GLI1 in Acute Myeloid Leukemia

Metis Hasipek, PhD, Sayer Al-Harbi, PhD, James G Phillips, PhD, Bartlomiej P. Przychodzen, MSc, Alek Nielsen, BS, Yihong Guan, PhD, Dale Grabowski, BS, Phillip J Maciejewski, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski, PhD MD FACP, Babal K Jha, PhD

Blood (2017) 130 (Supplement 1): 2654.

https://doi.org/10.1182/blood.V130.Suppl_1.2654.2654

Published: 2017

Journal Articles

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Laura A. Zider, MSN, ACNP-BC, RN, Amanda N. Seddon, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Jamile M. Shammo, MD, Gorgun Akpek, MD MHS

Blood (2016) 128 (22): 5876.

https://doi.org/10.1182/blood.V128.22.5876.5876

Published: 2016

Journal Articles

Successful Early Outcome with Low-Dose (400 cGY) Total Body Irradiation in Combination with Busulfan and Fludarabine Myeloablative Conditioning Followed By Matched Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Non-Remission Acute Myelogeneous Leukemia with Diffuse Extramedullary Disease in Multiple Sites

Gorgun Akpek, MD MHS, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Deborah A. Katz, MD, Ashley Echeverria, PA-C, Lindsay Hodges, RN, APN, Aidnag Z. Diaz, MD MPH, Ross Allen Abrams, MD

Blood (2016) 128 (22): 5769.

https://doi.org/10.1182/blood.V128.22.5769.5769

Published: 2016

Journal Articles

Bridging to Second Allogeneic Peripheral Blood Stem Cell Transplantation with Nelarabine in a Patient with Multiply Relapsed/Refractory T-Cell ALL

Jacqueline Baptista, RN, APN, Eris Tollkuci, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Melissa L. Larson, MD, Gorgun Akpek, MD MHS

Blood (2016) 128 (22): 5200.

https://doi.org/10.1182/blood.V128.22.5200.5200

Published: 2016

Journal Articles

Engraftment Kinetics After Alimtuzumab-Based Allogeneic Stem Cell Transplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVHD) or CMV Reactivation

Henry C. Fung, FRCP, MD, Muhammed Alikhan, Lela Buckingham, PhD, John J. Maciejewski, MD, PhD, Reem Karmali, MD, Kent W Christopherson, II, PhD, Elizabeth Shima Rich, MD, PhD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Sunita Nathan, MD

Blood (2012) 120 (21): 4162.

https://doi.org/10.1182/blood.V120.21.4162.4162

Published: 2012

Journal Articles

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

Henry C. Fung, FRCP, MD, Sunita Nathan, MD, Neel B. Shah, MD, John J. Maciejewski, MD, PhD, Elizabeth Shima Rich, MD, PhD, Jennifer Tornatta, MS, ANP, Nancy Licciardi, Parameswaran Venugopal, MD, Reem Karmali, MD, Stephanie A. Gregory, MD

Blood (2011) 118 (21): 4205.

https://doi.org/10.1182/blood.V118.21.4205.4205

Published: 2011

Journal Articles

Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant,

Jennifer Tornatta, MS, ANP, John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Bruce Mcleod, MD, Sridevi Palaparthy, MBA, MS, Elizabeth Shima Rich, MD, PhD, Kent W Christopherson, II, PhD, Stephanie A. Gregory, MD, Henry C. Fung, FRCP, MD

Blood (2011) 118 (21): 4061.

https://doi.org/10.1182/blood.V118.21.4061.4061

Published: 2011

Journal Articles

Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.

Jennifer Tornatta, RN, MSN, ANP-BC, John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Bruce C. McLeod, MD, Darilyn Rhoades, RN, Sridevi Palaparthy, MBA, MS, Henry C. Fung

Blood (2009) 114 (22): 3218.

https://doi.org/10.1182/blood.V114.22.3218.3218

Published: 2009

Journal Articles

The Transplant Outcomes of a 10/10 Matched Unrelated Donor (MUD) Stem Cell Transplant (SCT) Is Similar to a HLA Identical Related Donor (RD) Transplant.

Catherine Veeder, MD, Sheila Davies, R.N., OCN, Christina Havey, R.N., John J. Maciejewski, MD, PhD, Sunita Nathan, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Jamile Shammo, MD, Henry C. Fung, MD

Blood (2009) 114 (22): 4346.

https://doi.org/10.1182/blood.V114.22.4346.4346

Published: 2009

Journal Articles

Reversal of Renal Insufficiency after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Hande Hayirlioglu Tuncer, MD, John J. Maciejewski, MD, PhD, Stephanie A Gregory, MD, Henry C. Fung, MD

Blood (2008) 112 (11): 4330.

https://doi.org/10.1182/blood.V112.11.4330.4330

Published: 2008

Journal Articles

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

Neel B. Shah, MD, Melissa L. Larson, MD, Nitin Goyal, Ann M. Thomas, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4004.

https://doi.org/10.1182/blood.V112.11.4004.4004

Published: 2008

Journal Articles

Efficacy of a Two Day Induction Regimen for De Novo and Secondary AML with Intermediate and Adverse Cytogenetic Profiles

Melissa L. Larson, MD, Ann M. Thomas, Nitin Goyal, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4027.

https://doi.org/10.1182/blood.V112.11.4027.4027

Published: 2008

Journal Articles

Tolerability of An Effective Two Day Induction Regimen for Newly Diagnosed AML

Melissa L. Larson, MD, Nitin Goyal, Ann M. Thomas, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4035.

https://doi.org/10.1182/blood.V112.11.4035.4035

Published: 2008

Journal Articles

Regulatory T Cells Do Not Affect Human Hematopoietic Stem Cell Engraftment and Prevent T Cell Alloreactivity Against CD34+ Cells: A Preclinical Study.

Dolores Mahmud, PhD, Sandeep Chunduri, MD, Nadim Mahmud, MD, PhD, Lennert Van Den Dries, MS, John J. Maciejewski, MD, PhD, Damiano Rondelli, MD

Blood (2007) 110 (11): 4870.

https://doi.org/10.1182/blood.V110.11.4870.4870

Published: 2007

Journal Articles

Large CD45 Protein Tyrosine Phosphatase (PTP) Isoforms Predominate in Myelodysplastic Erythroid Precursors and Attenuate the Erythropoietin (EPO): STAT5 Signal.

Alan List, MD, M. Estes, G. Gao, Ph.D, A. Janokowska, J. Maciejewski, M.D.

Blood (2006) 108 (11): 2650.

https://doi.org/10.1182/blood.V108.11.2650.2650

Published: 2006

Journal Articles

Umbilical Cord Blood (UCB) Graft T-Cells Correlate with Myeloid Recovery in Adults with Hematologic Malignancies Treated with Reduced Intensity Conditioning (RIC) and Single Unit Infusion.

Y. Hegerfeldt, L.R. Fanning, P. Fu, H.M. Lazarus, B. Cooper, W. Tse, H. Meyerson, S.L. Gerson, J. Jaroscak, R. Fox, R. Creger, J. Maciejewski, M. Tary-Lehmann, M. Ratajczak, C. Stevens, P. Rubinstein, M.A. Hoffman, Mary J. Laughlin

Blood (2006) 108 (11): 3132.

https://doi.org/10.1182/blood.V108.11.3132.3132

Published: 2006

Journal Articles

Umbilical Cord Blood Derived CD133+ Hematopoietic Stem Cells Are Defective Antigen Presenting Cells (APC), Lack Expression of Co-Stimulatory Receptors, and Generate TH 2 T-Lymphocyte Responses In Vitro.

L.R. Fanning, M.R. Finney, V.J. Pompili, N.J. Greco, H.M. Lazarus, M. Kozik, H. Meyerson, R. Nair, J. Maciejewski, M. Tary-Lehmann, M. Ratajczak, Mary J. Laughlin

Blood (2006) 108 (11): 1723.

https://doi.org/10.1182/blood.V108.11.1723.1723

Published: 2006

Journal Articles

Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro

J Maciejewski, C Selleri, S Anderson, NS Young

Blood (1995) 85 (11): 3183–3190.

https://doi.org/10.1182/blood.V85.11.3183.bloodjournal85113183

Published: 1995

NARROW

Reversible TET Inhibitor As a Hematopoietic Stem Cell Booster: A Novel Strategy to Improve Stem Cell Function

Targeting NAD + Modulating Enzymes to Improve HSC Function in Aging and Bone Marrow Failure

Therapeutic Targeting of GLI1 in Acute Myeloid Leukemia

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Bridging to Second Allogeneic Peripheral Blood Stem Cell Transplantation with Nelarabine in a Patient with Multiply Relapsed/Refractory T-Cell ALL

Engraftment Kinetics After Alimtuzumab-Based Allogeneic Stem Cell Transplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVHD) or CMV Reactivation

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant,

Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.

The Transplant Outcomes of a 10/10 Matched Unrelated Donor (MUD) Stem Cell Transplant (SCT) Is Similar to a HLA Identical Related Donor (RD) Transplant.

Reversal of Renal Insufficiency after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

Efficacy of a Two Day Induction Regimen for De Novo and Secondary AML with Intermediate and Adverse Cytogenetic Profiles

Tolerability of An Effective Two Day Induction Regimen for Newly Diagnosed AML

Regulatory T Cells Do Not Affect Human Hematopoietic Stem Cell Engraftment and Prevent T Cell Alloreactivity Against CD34+ Cells: A Preclinical Study.

Large CD45 Protein Tyrosine Phosphatase (PTP) Isoforms Predominate in Myelodysplastic Erythroid Precursors and Attenuate the Erythropoietin (EPO): STAT5 Signal.

Umbilical Cord Blood (UCB) Graft T-Cells Correlate with Myeloid Recovery in Adults with Hematologic Malignancies Treated with Reduced Intensity Conditioning (RIC) and Single Unit Infusion.

Umbilical Cord Blood Derived CD133+ Hematopoietic Stem Cells Are Defective Antigen Presenting Cells (APC), Lack Expression of Co-Stimulatory Receptors, and Generate TH 2 T-Lymphocyte Responses In Vitro.

Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only